282 related articles for article (PubMed ID: 27225824)
1. Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives.
Thambi T; Park JH; Lee DS
Chem Commun (Camb); 2016 Jun; 52(55):8492-500. PubMed ID: 27225824
[TBL] [Abstract][Full Text] [Related]
2. Modulating tumor hypoxia by nanomedicine for effective cancer therapy.
Jahanban-Esfahlan R; de la Guardia M; Ahmadi D; Yousefi B
J Cell Physiol; 2018 Mar; 233(3):2019-2031. PubMed ID: 28198007
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-activated nanomedicines for effective cancer therapy.
Zhou M; Xie Y; Xu S; Xin J; Wang J; Han T; Ting R; Zhang J; An F
Eur J Med Chem; 2020 Jun; 195():112274. PubMed ID: 32259703
[TBL] [Abstract][Full Text] [Related]
4. Rationally designed DNA-based nanocarriers.
Jiang Q; Zhao S; Liu J; Song L; Wang ZG; Ding B
Adv Drug Deliv Rev; 2019 Jul; 147():2-21. PubMed ID: 30769047
[TBL] [Abstract][Full Text] [Related]
5. Silicon nanostructures for cancer diagnosis and therapy.
Peng F; Cao Z; Ji X; Chu B; Su Y; He Y
Nanomedicine (Lond); 2015; 10(13):2109-23. PubMed ID: 26135645
[TBL] [Abstract][Full Text] [Related]
6. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy.
Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z
J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.
Linton SS; Sherwood SG; Drews KC; Kester M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):208-22. PubMed ID: 26153136
[TBL] [Abstract][Full Text] [Related]
9. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
[TBL] [Abstract][Full Text] [Related]
10. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
13. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
14. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy.
Zhou H; Qin F; Chen C
Adv Healthc Mater; 2021 Mar; 10(5):e2001277. PubMed ID: 32985141
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
Kanamala M; Wilson WR; Yang M; Palmer BD; Wu Z
Biomaterials; 2016 Apr; 85():152-67. PubMed ID: 26871891
[TBL] [Abstract][Full Text] [Related]
16. Charge-reversal nanocarriers: An emerging paradigm for smart cancer nanomedicine.
Zhang M; Chen X; Li C; Shen X
J Control Release; 2020 Mar; 319():46-62. PubMed ID: 31846619
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review.
Kumari R; Sunil D; Ningthoujam RS
J Control Release; 2020 Mar; 319():135-156. PubMed ID: 31881315
[TBL] [Abstract][Full Text] [Related]
18. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
Monteiro PF; Travanut A; Conte C; Alexander C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.
Zhang RX; Wong HL; Xue HY; Eoh JY; Wu XY
J Control Release; 2016 Oct; 240():489-503. PubMed ID: 27287891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
